ResMed Inc. (ASX: RMD)
28.38
+0.05 (0.18%)
Jul 3, 2024, 4:10 PM AEST
ResMed Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 - 1993 |
---|---|---|---|---|---|---|
Cash & Equivalents | 227.89 | 295.28 | 463.16 | 147.13 | 147.13 | Upgrade
|
Short-Term Investments | 12.42 | 9.17 | 0 | 0 | 0 | Upgrade
|
Cash & Cash Equivalents | 227.89 | 295.28 | 463.16 | 147.13 | 147.13 | Upgrade
|
Cash Growth | -22.82% | -36.25% | 214.80% | 0% | -22.03% | Upgrade
|
Receivables | 704.91 | 614.29 | 474.64 | 528.48 | 528.48 | Upgrade
|
Inventory | 998.01 | 457.03 | 416.92 | 349.64 | 349.64 | Upgrade
|
Other Current Assets | 424.6 | 198.99 | 168.75 | 120.11 | 120.11 | Upgrade
|
Total Current Assets | 2,368 | 1,575 | 1,523 | 1,145 | 1,145 | Upgrade
|
Property, Plant & Equipment | 665.81 | 592.07 | 535.68 | 387.46 | 387.46 | Upgrade
|
Long-Term Investments | -132.97 | -240.82 | -189.74 | -196.46 | 52.1 | Upgrade
|
Goodwill | 2,770 | 1,928 | 1,890 | 1,856 | 1,856 | Upgrade
|
Intangible Assets | 552.34 | 392.58 | 448.17 | 521.95 | 521.95 | Upgrade
|
Other Long-Term Assets | 528.4 | 481.64 | 379.48 | 392.91 | 144.35 | Upgrade
|
Total Long-Term Assets | 4,384 | 3,153 | 3,064 | 2,962 | 2,962 | Upgrade
|
Total Assets | 6,752 | 4,728 | 4,587 | 4,108 | 4,108 | Upgrade
|
Accounts Payable | 150.76 | 138.01 | 135.79 | 115.73 | 115.73 | Upgrade
|
Deferred Revenue | 138.07 | 109.61 | 98.62 | 88.67 | 88.67 | Upgrade
|
Current Debt | 31.82 | 35.59 | 33.25 | 11.99 | 11.99 | Upgrade
|
Other Current Liabilities | 437.88 | 628.56 | 335.11 | 339.61 | 339.61 | Upgrade
|
Total Current Liabilities | 758.53 | 911.77 | 602.76 | 555.99 | 555.99 | Upgrade
|
Long-Term Debt | 1,548 | 758.13 | 1,266 | 1,259 | 1,259 | Upgrade
|
Other Long-Term Liabilities | 315.19 | 172.55 | 221.58 | 220.64 | 220.64 | Upgrade
|
Total Long-Term Liabilities | 1,863 | 930.68 | 1,488 | 1,479 | 1,479 | Upgrade
|
Total Liabilities | 2,622 | 1,842 | 2,090 | 2,035 | 2,035 | Upgrade
|
Total Debt | 1,580 | 793.72 | 1,299 | 1,271 | 1,271 | Upgrade
|
Debt Growth | 99.05% | -38.91% | 2.24% | - | 351.53% | Upgrade
|
Common Stock | 0.59 | 0.58 | 0.58 | 0.58 | 0.58 | Upgrade
|
Retained Earnings | 4,253 | 3,080 | 2,833 | 2,436 | 2,436 | Upgrade
|
Comprehensive Income | -272.53 | -193.49 | -283.98 | -253.01 | -253.01 | Upgrade
|
Shareholders' Equity | 4,130 | 2,886 | 2,497 | 2,072 | 2,072 | Upgrade
|
Total Liabilities and Equity | 6,752 | 4,728 | 4,587 | 4,108 | 4,108 | Upgrade
|
Net Cash / Debt | -1,339.59 | -489.27 | -836.11 | -1,123.73 | -1,123.73 | Upgrade
|
Net Cash Per Share | -0.91 | -0.33 | -0.57 | -0.78 | -0.78 | Upgrade
|
Working Capital | 1,609 | 662.99 | 920.7 | 589.38 | 589.38 | Upgrade
|
Book Value Per Share | 2.81 | 1.98 | 1.72 | 1.44 | 1.45 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.